Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Saved in:
| Title: | Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial. |
|---|---|
| Authors: | Amat‐Santos, Ignacio J.1,2 (AUTHOR), Sánchez‐Luna, Juan P.1,2 (AUTHOR), Abu‐Assi, Emad3 (AUTHOR), Melendo‐Viu, María3 (AUTHOR), Cruz‐Gonzalez, Ignacio4 (AUTHOR), Nombela‐Franco, Luis5 (AUTHOR), Muñoz‐Garcí, Antonio J.1,6 (AUTHOR), Blas, Sergio G.7 (AUTHOR), de la Torre Hernandez, Jose M.8 (AUTHOR), Romaguera, Rafael9 (AUTHOR), Sánchez‐Recalde, Ángel10 (AUTHOR), Diez‐Gil, José L.11 (AUTHOR), Lopez‐Otero, Diego1,12 (AUTHOR), Gheorge, Livia13 (AUTHOR), Ibáñez, Borja1,14,15 (AUTHOR), Iñiguez‐Romo, Andrés3 (AUTHOR), Raposeiras‐Roubín, Sergio3,15 (AUTHOR) raposeiras26@hotmail.com, Muñoz‐García, Erika (AUTHOR), Sanz‐Sánchez, Jorge (AUTHOR), Pereiro‐Montes, Diana (AUTHOR) |
| Source: | European Journal of Heart Failure. Mar2022, Vol. 24 Issue 3, p581-588. 8p. 2 Diagrams, 3 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
